X
X
Leaving Community
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
No
Yes
Welcome to Data Science Corner Virtual Booth
NIDDK Data Science Corner Program Presentation Schedule
June 20, 2025 (Fri)
| Time Slot | Location | Program | Session Type | Presentation Title | Presenter |
|---|---|---|---|---|---|
| 12:45-1:45 pm CT | W185 A-D | TrialNet | Oral Presentation | Lower Incretin Effect and Reduced GIP Characterize the Metabolic Phenotype of People with Multiple Islet Autoantibodies and Normal Glucose Tolerance | Dr. Alfonso Galderisi |
| 3:30-3:15 pm CT | W145 A-D | RADIANT (Rare and Atypical Diabetes Network) | Oral Presentation |
Leveraging Population Diversity to Improve Understanding of the Genetic Etiology of Type 1 and Type 2 Diabetes (With ADA Presidents' Select Abstract Presentation). Oral Presentation: Novel Syndromic Forms of Diabetes within the Rare and Atypical Diabetes Network (RADIANT) |
Dr. Stephen Stone |
| 6:30-8:30 pm CT | Booth #847, 943, 944, 945, 947, 948, 1044, 1045, 1047, 1048 at Exhibition Hall | All programs | Networking | NIDDK Data Science Corner @ADA Networking Reception | Exhibitors |
June 21, 2025 (Sat)
| Time Slot | Location | Program | Session Type | Presentation Title | Presenter |
|---|---|---|---|---|---|
| 12:30-12:45 pm CT | Booth #1047 at Exhibition Hall | PanKbase | Platform Demo | PanKase: A centralized knowledgebase of the human pancreas for diabetes research | Drs. Ha Vu, Julie Jurgens and Noel Brutt |
| 12:30-1:30 pm CT | Poster Hall [Board No. 2123] |
RADIANT (Rare and Atypical Diabetes Network) | Poster | Discovery of CERS2 Haploinsufficiency Causing Atypical Lipodystrophy and Severe Fatty Liver Disease—Utility of Multiomics Analyses in the RADIANT study | Dr. Maria Foss-Freitas |
| 12:30-1:30 pm CT | Poster Hall [Board No. 2124] |
RADIANT (Rare and Atypical Diabetes Network) | Poster | Characteristics of People with Monogenic Diabetes in the Rare and Atypical Diabetes Network (RADIANT) Cohort | Julia Douvas |
| 12:30-1:30 pm CT | Poster Hall [Board No. 2128] |
RADIANT (Rare and Atypical Diabetes Network) | Poster | Novel Predicted Loss of Function Variants in TRIP10/CIP4 Associated with Atypical Diabetes in Two Unrelated Individuals | Dr. Stephen Stone |
| 12:30-1:30 pm CT | Poster Hall [Board No. 2130] |
RADIANT (Rare and Atypical Diabetes Network) | Poster | Novel Insulin Gene Variants in Antibody-Negative Adult-Onset Diabetes | Dr. David Broome |
| 12:30-1:30 pm CT | Poster Hall [Board No. 691] |
TrialNet | Poster | Quality of Life and Diabetes Distress among Children and Youth with Type 1 Diabetes and Their Parents in Kampala, Uganda—Cross-Sectional Survey | Dr. Brandon Nathan |
| 12:30-1:30 pm CT | Poster Hall [Board No. 705] |
TrialNet | Poster | Enhanced Detection of Efficacy in T1D Prevention Trials by Using Glucose Fractions | Dr. Brandon Nathan |
| 12:30-1:30 pm CT | Poster Hall [Board No. 712] |
TrialNet | Poster | Understanding Participant Decision Making for Enrolling in an Intervention Trial to Delay Stage 3 T1D | Dr. Holly O’Donnell |
| 12:30-1:30 pm CT | Poster Hall [Board No. 719] |
TrialNet | Poster | Oral Disposition Index (oDI) as an Outcome Measure in Type 1 Diabetes (T1D) Clinical Trials: Evidence from Stage 1 and Stage 2 T1D trials | Dr. Alfonso Galderisi |
| 12:30-1:30 pm CT | Poster Hall [Board No. 1510] |
TrialNet | Poster | An Insulin Secretion Independent Fraction of Glucose Obscures Associations of Age and BMI with Glucose in Autoantibody-Positive (Ab+) Individuals | Dr. Brandon Nathan |
| 12:30-1:30 pm CT | Poster Hall [Board No. 1523] |
TrialNet | Poster | Risk profiles and characteristics of individuals with single autoantibody (SAB) reversion in relatives at risk for Type 1 Diabetes (T1D) | Dr. Heba Ismail |
| 12:30-1:30 pm CT | Poster Hall [Board No. 1524] |
TrialNet | Poster | The Progression of 2-Hour Glucose (2hGLU) to Impaired Glucose Tolerance (IGT) and Its Reversion in Antibody-Positive (Ab+) Individuals? | Dr. Heba Ismail |
| 12:30-1:30 pm CT | Poster Hall [Board No. 1525] |
TrialNet | Poster | Genetic Ancestry and Progression through Type 1 Diabetes (T1D) Stages | Dr. Heba Ismail |
| 12:30-1:30 pm CT | Poster Hall [Board No. 726] |
TrialNet | Poster | Two-Year Follow-up of AVT001 Dendritic Cell Therapy for Type 1 Diabetes—Continued Off-Therapy Functional Effects and Characterization of Responders | Dr. Jason Gaglia |
| 2-2:30 pm CT | Booth #1044 at Exhibition Hall | NIDDK Central Repository (NIDDK-CR) Resources for Research (R4R) | Platform Demo | A Platform for Innovation: Driving Biomedical Insights Through Data Science Competitions | Anya Dabic Nilesh Mistry |
| 2:45-3:00 pm CT | W187 A-C | TrialNet | Oral Presentation | Evaluating the Impact of Type 1 Diabetes Interventions on A1C and GMI across Glycemic Categories | Dr. Eslam Montaser |
| 3:45-4:00 pm CT | Booth #1047 at Exhibition Hall | PanKbase | Platform Demo | PanKase: A centralized knowledgebase of the human pancreas for diabetes research | Drs. Ha Vu, Julie Jurgens and Noel Brutt |
| 6-7:30 pm CT | Hyatt Regency McCormick Place Grant Park D | AMP-CMDKP | Ancillary Session/Preesentation | Celebrate AMP-Common Metabolic Diseases Knowledge Portal’s 10 year anniversary at ADA with scientific talks and networking! | Dr. Noel Burtt MacKenzie Brandes |
June 22, 2025 (Sun)
| Time Slot | Location | Program | Session Type | Presentation Title | Presenter |
|---|---|---|---|---|---|
| 8:40-9:00 am CT | W181 A-C | TrialNet | Symposium | The Role of CGM in Staging Early Type 1 Diabetes | Dr. Andrea Steck |
| 11:30-12:30 pm CT | W187 A-C | TrialNet | Session Chair | Discussion on Diabetes in Youth—D-Tech and DEB—The Spectrum of Disordered Eating Behaviors in Children, Adolescents, and Young Adults Using Diabetes Devices | Dr. Heba Ismail |
| 12:30-12:45 pm CT | Booth #1047 at Exhibition Hall | PanKbase | Platform Demo | PanKase: A centralized knowledgebase of the human pancreas for diabetes research | Drs. Ha Vu, Julie Jurgens and Noel Brutt |
| 12:30-1:30pm CT | Poster Hall [Poster Number: 2099-LB] |
Covid-19 and Diabetes Assessment (CODA) | Poster | Relationship between COVID-19 Variants and Diabetes Incidence | Dr. Jason Block |
| 12:30-1:30pm CT | Poster Hall [Board No. 1962] |
TrialNet | Poster | Baseline Insulin Secretion Determines the Response to Abatacept in Stage 1 Type 1 Diabetes | Dr. Alice Carr |
| 12:30-1:30pm CT | Poster Hall [Board No. 2121-LB] |
PanKbase | Poster | PanKbase Integrated Single-Cell Map—A Comprehensive Atlas of Human Pancreatic Islets Unlocking Insights into Type 1 and Type 2 Diabetes | Dr. Ha Vu |
| 3:15-4:15 pm CT | W196 BC | TrialNet | Panel Discussion | Panel Discussion – Encapsulation vs. Naked Cell Therapy—Immune Challenges and Beta-Cell Perspectives in Diabetes Treatment | Dr. Mark Atkinson |
| 3:45-4:00 pm CT | Booth #1047 at Exhibition Hall | PanKbase | Platform Demo | PanKase: A centralized knowledgebase of the human pancreas for diabetes research | Drs. Ha Vu, Julie Jurgens, and Noel Brutt |
June 23, 2025 (Mon)
| Time Slot | Location | Program | Session Type | Presentation Title | Presenter |
|---|---|---|---|---|---|
| 8:40-9:00am CT | W185 A-D | TrialNet | Symposium | Ketone Sensor Performance Criteria and Current Study Data | Dr. Jennifer Sherr |
| 12:50-1:00pm CT | Poster Hall [Board No. 726] |
TrialNet | ePoster Theater | Two-Year Follow-up of AVT001 Dendritic Cell Therapy for Type 1 Diabetes—Continued Off-Therapy Functional Effects and Characterization of Responders | Dr. Jason Gaglia |
| 1:50-2:10pm CT | W184 A-D | TEDDY; Type 1 Diabetes TrialNet | Symposium presentation | Today's Reality of Achieving Type 1 Prevention. Part of Symposium: "Celebrating NIDDK's 75th Anniversary—Clinical, Translational and Basic Advances, Current Research Priorities and Future Direction" | Dr. Jeffrey Krischer |
| 3:15-4:15 pm CT | W192 A-C | dkNET (NIDDK Information Network) | Panel Discussion/Presentation | Panel Discussion - Decoding Diabetes—AI-Driven Advances in Genetic Research. Presentation: Diabetes Disease Modeling in the Era of AI | Dr. Wei Wang |